DOTA-amide (dihydrate)
Product Specifications
UNSPSC Description
DOTA-amide (dihydrate) is a Bifunctional Chelators (BFCs). DOTA-amide (dihydrate) binds to the Affibody molecule ZHER2:S1. Its complex binds specifically to HER2 and can be used to detect bone metastases, which are common in prostate cancer[1].
Target Antigen
Biochemical Assay Reagents
Type
Biochemical Assay Reagents
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dota-amide-dihydrate.html
Solubility
10 mM in DMSO
Smiles
O=C(N)CN1CCN(CC(N)=O)CCN(CC(N)=O)CCN(CC(N)=O)CC1.O.O
Molecular Weight
436.51
References & Citations
[1]Malmberg J, et al.Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts. Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):481-92
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-W088413A/DOTA-amide-dihydrate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W088413A/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6345734-01 0.2 mL
SEC14L4, NT (SEC14L4, TAP3, SEC14-like protein 4, Tocopherol-associated protein 3) (AP)
Ask
View Details MBS6345734-02 5x 0.2 mL
SEC14L4, NT (SEC14L4, TAP3, SEC14-like protein 4, Tocopherol-associated protein 3) (AP)
Ask
View Details